Acute management

This study suggests that early treatment with corticosteroids on top of standard therapy reduces the risk of serious heart problems in children under five with Kawasaki Disease.

An article on the diagnosis and treatment of Kawasaki Disease.

This systematic review and meta-analysis demonstrates that adjunctive corticosteroid therapy was associated with a significantly lower rate of coronary artery complication compared with intravenous immunoglobulin therapy, particularly among high-risk patients.

A paper evaluating the effect of corticosteroid therapy in KD.

This paper explores the acute dermatologic manifestations of Kawasaki Disease

This paper sets out the UK recommended guidance for patient management and clinical care for acute Kawasaki Disease and indicates long term care needs, together with summarising recent advances in the understanding of KD pathogenesis and therapeutics.

Intravenous immunoglobulin plus corticosteroids prevent coronary artery abnormalities in Kawasaki disease

A case is reported of classical Kawasaki disease in an infant younger than 2 weeks of age. Echocardiography detected a coronary artery aneurysm on the fifth day of the illness. prompt treatment resulted in rapid improvement. Kawasaki Disease is not common in neonates, but it may follow a rapid and severe course.